Your session is about to expire
← Back to Search
Educational Intervention for HPV Vaccination (PARENT Trial)
N/A
Waitlist Available
Led By Electra Paskett
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at whether an educational intervention can increase HPV vaccination rates in younger girls in Ohio Appalachia.
Who is the study for?
This trial is for English-speaking parents in Ohio Appalachia with daughters aged 9-17 who haven't received the HPV vaccine, and healthcare providers involved in vaccinations at participating locations. Parents of vaccinated children or those outside the specified counties are excluded.
What is being tested?
The study tests an educational program aimed at parents and healthcare providers to see if it increases HPV vaccination rates among young girls in Ohio Appalachia.
What are the potential side effects?
Since this is an educational intervention, there are no direct medical side effects. However, participants may experience changes in knowledge or attitudes about HPV vaccination.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of daughters of participating parents who received their first HPV vaccination
Secondary study objectives
Proportion of daughters of participants in the intervention arm who received a second and third dose of the HPV vaccine
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I-HPV vaccine educationExperimental Treatment1 Intervention
The educational intervention is that parents and providers receive materials about HPV by mail including HPV/ cervical cancer videos and brochures, fact sheets, HPV/cervical cancer resource lists. Clinics receive posters, brochures, tabletop/reminder cards, resource lists, newsletters, and "invitation to be vaccinated" letters for parents.
Group II: Arm II- Flu vaccine educationActive Control1 Intervention
The educational intervention is that parents and providers receive materials about Flu by mail including Flu brochures, fact sheets, Flu resource lists. Clinics receive posters and brochures.
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
340 Previous Clinical Trials
292,686 Total Patients Enrolled
Electra PaskettPrincipal InvestigatorOhio State University Comprehensive Cancer Center
2 Previous Clinical Trials
6,409 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent or guardian of an unvaccinated girl aged 9 to 17.I am not a parent or guardian of an unvaccinated girl aged 9 to 17.
Research Study Groups:
This trial has the following groups:- Group 1: Arm II- Flu vaccine education
- Group 2: Arm I-HPV vaccine education
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.